Interleukin-1β, tumour necrosis factor-α and lipopolysaccharide induce C-type natriuretic peptide from canine aortic endothelial cells

Research in Veterinary Science

Volumn 94, Issue 3, 2013, Pages 478-483

  Osterbur, Kara ^a   Yu, Do Hyeon ^a   DeClue, Amy E ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Inflammatory mediators; Pathogen associated molecular patterns; Sepsis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; NATRIURETIC PEPTIDE TYPE C; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; AORTA; ARTICLE; CELL STIMULATION; CELL VIABILITY; CELLULAR SECRETION; CONTROLLED STUDY; DOG; ENDOTHELIUM CELL; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; INTERLEUKINS; LEUKOCYTES; LIPOPOLYSACCHARIDES; NATRIURETIC PEPTIDE, C-TYPE; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

CANIS FAMILIARIS;

EID: 84876153338     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2012.10.002     Document Type: Article

References (42)

1. Bahrami S., Pelinka L., Khadem A., Maitzen S., Hawa G., van Griensven M., Redl H. Circulating NT-proCNP predicts sepsis in multiple-traumatized patients without traumatic brain injury. Critical Care Medicine 2010, 38:161-166.
2. Beaulieu P., Cardinal R., Page P., Francoeur F., Tremblay J., Lambert C. Positive chronotropic and inotropic effects of C-type natriuretic peptide in dogs. American Journal of Physiology 1997, 273:H1933-H1940.
3. Benbarek H., Deby-Dupont G., Caudron I., Deby C., Lamy M., Serteyn D. Failure of lipopolysaccharides to directly trigger the chemiluminescence response of isolated equine polymorphonuclear leukocytes. Veterinary Research Communication 1997, 21:477-482.
4. Blier A.S., Veron W., Bazire A., Gerault E., Taupin L., Vieillard J., Rehel K., Dufour A., Le Derf F., Orange N., Hulen C., Feuilloley M.G., Lesouhaitier O. C-type natriuretic peptide modulates quorum sensing molecule and toxin production in Pseudomonas aeruginosa. Microbiology 2011, 157:1929-1944.
5. DeClue A.E., Cohn L.A., Lechner E.S., Bryan M.E., Dodam J.R. Effects of subanesthetic doses of ketamine on hemodynamic and immunologic variables in dogs with experimentally induced endotoxemia. American Journal of Veterinary Research 2008, 69:228-232.
6. DeClue A.E., Osterbur K., Bigio A., Sharp C.R. Evaluation of serum NT-pCNP as a diagnostic and prognostic biomarker for sepsis in dogs. Journal of Veterinary Internal Medicine 2011, 25:453-459.
7. DeClue A.E., Sharp C.R., Harmon M. Plasma inflammatory mediator concentrations at ICU admission in dogs with naturally developing sepsis. Journal of Veterinary Internal Medicine 2012, 26:624-630.
8. Del Ry S., Cabiati M., Stefano T., Catapano G., Caselli C., Prescimone T., Passino C., Emdin M., Giannessi D. Comparison of NT-proCNP and CNP plasma levels in heart failure, diabetes and cirrhosis patients. Regulatory Peptides 2011, 166:15-20.
9. Figueiredo M.D., Salter C.E., Hurley D.J., Moore J.N. A comparison of equine and bovine sera as sources of lipopolysaccharide-binding protein activity in equine monocytes incubated with lipopolysaccharide. Veterinary Immunology and Immunopathology 2008, 121:275-280.
10. Fowler B.L., Axiak S.M., DeClue A.E. Blunted pathogen-associated molecular pattern motif induced TNF, IL-6 and IL-10 production from whole blood in dogs with lymphoma. Veterinary Immunology and Immunopathology 2011, 144:167-171.
11. Grone A., Frisk A.L., Baumgartner W. Cytokine mRNA expression in whole blood samples from dogs with natural canine distemper virus infection. Veterinary Immunology and Immunopathology 1998, 65:11-27.
12. Grone A., Alldinger S., Baumgartner W. Interleukin-1beta, -6, -12 and tumor necrosis factor-alpha expression in brains of dogs with canine distemper virus infection. Journal of Neuroimmunology 2000, 110:20-30.
13. Guedes P.M., Veloso V.M., Afonso L.C., Caliari M.V., Carneiro C.M., Diniz L.F., Marques-da-Silva E.A., Caldas I.S., Do Valle Matta M.A., Souza S.M., Lana M., Chiari E., Galvao L.M., Bahia M.T. Development of chronic cardiomyopathy in canine Chagas disease correlates with high IFN-gamma, TNF-alpha, and low IL-10 production during the acute infection phase. Veterinary Immunology and Immunopathology 2009, 130:43-52.
14. Hama N., Itoh H., Shirakami G., Suga S., Komatsu Y., Yoshimasa T., Tanaka I., Mori K., Nakao K. Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients. Biochemical and Biophysical Research Communication 1994, 198:1177-1182.
15. Hutchinson H.G., Trindade P.T., Cunanan D.B., Wu C.F., Pratt R.E. Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells. Cardiovascular Research 1997, 35:158-167.
16. Koch A., Voigt S., Sanson E., Duckers H., Horn A., Zimmermann H.W., Trautwein C., Tacke F. Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients. Critical Care 2011, 15:R45.
17. Korinek J., Boerrigter G., Mohammed S.F., Burnett J.C. Insights into natriuretic peptides in heart failure: an update. Current Heart Failure Report 2008, 5:97-104.
18. Kubo A., Isumi Y., Ishizaka Y., Tomoda Y., Kangawa K., Dohi K., Matsuo H., Minamino N. C-type natriuretic peptide is synthesized and secreted from leukemia cell lines, peripheral blood cells, and peritoneal macrophages. Experimental Hematology 2001, 29:609-615.
19. Mericq V., Uyeda J.A., Barnes K.M., De Luca F., Baron J. Regulation of fetal rat bone growth by C-type natriuretic peptide and cGMP. Pediatric Research 2000, 47:189-193.
20. Miyamoto T., Fujinaga T., Yamashita K., Hagio M. Changes of serum cytokine activities and other parameters in dogs with experimentally induced endotoxic shock. The Japanese Journal of Veterinary Research 1996, 44:107-118.
21. Okano S., Hurley D.J., Vandenplas M.L., Moore J.N. Effect of fetal bovine serum and heat-inactivated fetal bovine serum on microbial cell wall-induced expression of procoagulant activity by equine and canine mononuclear cells in vitro. American Journal of Veterinary Research 2006, 67:1020-1024.
22. Otto C.M., Drobatz K.J., Soter C. Endotoxemia and tumor necrosis factor activity in dogs with naturally occurring parvoviral enteritis. Journal of Veterinary Internal Medicine 1997, 11:65-70.
23. Palmer S.C., Prickett T.C., Espiner E.A., Yandle T.G., Richards A.M. Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac function. Hypertension 2009, 54:612-618.
24. Peter A.T., Ash S.R., Steczko J., Turek J.J., Blake D.E., Carr D.J., Knab W.R., Bosley R.H. Push-pull sorbent-based pheresis treatment in an experimental canine endotoxemia model: preliminary report. International Journal of Artificial Organs 1999, 22:177-188.
25. Piechota M., Banach M., Jacon A., Rysz J. Natriuretic peptides in cardiovascular diseases. Cellular and Molecular Biology Letters 2008, 13:155-181.
26. Prickett T.C., Yandle T.G., Nicholls M.G., Espiner E.A., Richards A.M. Identification of amino-terminal pro-C-type natriuretic peptide in human plasma. Biochemical and Biophysical Research Communications 2001, 286:513-517.
27. Schumann R.R., Leong S.R., Flaggs G.W., Gray P.W., Wright S.D., Mathison J.C., Tobias P.S., Ulevitch R.J. Structure and function of lipopolysaccharide binding protein. Science 1990, 249:1429-1431.
28. Scotland R.S., Cohen M., Foster P., Lovell M., Mathur A., Ahluwalia A., Hobbs A.J. C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:14452-14457.
29. Steinemann S., Ulevitch R.J., Mackman N. Role of the lipopolysaccharide (LPS)-binding protein/CD14 pathway in LPS induction of tissue factor expression in monocytic cells. Arteriosclerosis, Thrombosis and Vascular Biology 1994, 14:1202-1209.
30. Stich A.N., DeClue A.E. Pathogen associated molecular pattern-induced TNF, IL-1beta, IL-6 and CXCL-8 production from feline whole blood culture. Research in Veterinary Science 2011, 90:59-63.
31. Strasser A., Teltscher A., May B., Sanders C., Niedermuller H. Age-associated changes in the immune system of German shepherd dogs. Journal of Veterinary Medicine A, Physiology, Pathology, Clinical Medicine 2000, 47:181-192.
32. Suga S., Nakao K., Itoh H., Komatsu Y., Ogawa Y., Hama N., Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of " vascular natriuretic peptide system" Journal of Clinical Investigation 1992, 90:1145-1149.
33. Suga S., Itoh H., Komatsu Y., Ogawa Y., Hama N., Yoshimasa T., Nakao K. Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells - evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells. Endocrinology 1993, 133:3038-3041.
34. Tawaragi Y., Fuchimura K., Tanaka S., Minamino N., Kangawa K., Matsuo H. Gene and precursor structures of human C-type natriuretic peptide. Biochemical and Biophysical Research Communications 1991, 175:645-651.
35. Tolsa J.F., Gao Y., Sander F.C., Souici A.C., Moessinger A., Raj J.U. Differential responses of newborn pulmonary arteries and veins to atrial and C-type natriuretic peptides. American Journal of Physiology and Heart Circular Physiology 2002, 282:H273-280.
36. Van Amersfoort E.S., Van Berkel T.J., Kuiper J. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clinical Microbiology Review 2003, 16:379-414.
37. Veron W., Orange N., Feuilloley M.G., Lesouhaitier O. Natriuretic peptides modify Pseudomonas fluorescens cytotoxicity by regulating cyclic nucleotides and modifying LPS structure. BMC Microbiology 2008, 8:114.
38. Vollmar A.M., Schulz R. Expression and differential regulation of natriuretic peptides in mouse macrophages. Journal of Clinical Investigation 1995, 95:2442-2450.
39. Vollmar A.M., Gerbes A.L., Nemer M., Schulz R. Detection of C-type natriuretic peptide (CNP) transcript in the rat heart and immune organs. Endocrinology 1993, 132:1872-1874.
40. Wu C., Wu F., Pan J., Morser J., Wu Q. Furin-mediated processing of Pro-C-type natriuretic peptide. Journal of Biological Chemistry 2003, 278:25847-25852.
41. Yamamoto H., Sugitani A., Kitada H., Arima T., Nishiyama K., Motoyama K., Shiiba M., Kawano R., Morisaki T., Nakafusa Y., Tanaka M. Effect of FR167653 on pancreatic ischemia-reperfusion injury in dogs. Surgery 2001, 129:309-317.
42. Yasoda A., Ogawa Y., Suda M., Tamura N., Mori K., Sakuma Y., Chusho H., Shiota K., Tanaka K., Nakao K. Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway. Journal of Biological Chemistry 1998, 273:11695-11700.